Method for reducing oxalate
AssigneeGelTex Pharmaceuticals, Inc.
InventorsStephen Randall Holmes-Farley, W. Harry Mandeville, III
Life of this patent
Estimating the term…
Abstract
A method for reducing oxalate levels in a patient that includes administering to the patient a therapeutically effective amount of non-absorbable amine polymers such as a polymer characterized by a repeat unit having the formula: and salts and copolymers thereof, where n is a positive integer and x is zero or an integer between 1 and about 4.
Claims12
A method for reducing oxalate levels in a patient in need thereof comprising administering to said patient a therapeutically effective amount of one or more aliphatic amine polymers wherein the polymer is characterized by a repeat unit having a formula selected from the group consisting of:
- and salts and copolymers thereof wherein R1 and R2, independently, is H or a substituted or unsubstituted alkyl, alkylamino or aryl group and X is a pharmaceutically acceptable counterion.
A method for reducing oxalate levels in a patient in need thereof comprising administering to said patient a therapeutically effective amount of a substituted or unsubstituted polydiallylamine.
Dependencies are inferred from the claim text.